Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brough

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.
Allergy|December 2, 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paperSylwia Smolinska, Florin-Dan Popescu, Elena Izquierdo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2023
First update of the living European guideline (EuroGuiDerm) on atopic eczemaA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2025
European Guideline (EuroGuiDerm) on atopic eczema: Living updateA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2022
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populationsA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapyA Wollenberg, M Kinberger, B Arents, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.
Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.
Allergy|December 2, 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paperSylwia Smolinska, Florin-Dan Popescu, Elena Izquierdo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2023
First update of the living European guideline (EuroGuiDerm) on atopic eczemaA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2025
European Guideline (EuroGuiDerm) on atopic eczema: Living updateA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2022
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populationsA Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapyA Wollenberg, M Kinberger, B Arents, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.
Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.
Pageof 15